Krasic, J.; Skara, L.; Ulamec, M.; Katusic Bojanac, A.; Dabelic, S.; Bulic-Jakus, F.; Jezek, D.; Sincic, N.
Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source. Cancers 2020, 12, 3416.
https://doi.org/10.3390/cancers12113416
AMA Style
Krasic J, Skara L, Ulamec M, Katusic Bojanac A, Dabelic S, Bulic-Jakus F, Jezek D, Sincic N.
Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source. Cancers. 2020; 12(11):3416.
https://doi.org/10.3390/cancers12113416
Chicago/Turabian Style
Krasic, Jure, Lucija Skara, Monika Ulamec, Ana Katusic Bojanac, Sanja Dabelic, Floriana Bulic-Jakus, Davor Jezek, and Nino Sincic.
2020. "Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source" Cancers 12, no. 11: 3416.
https://doi.org/10.3390/cancers12113416
APA Style
Krasic, J., Skara, L., Ulamec, M., Katusic Bojanac, A., Dabelic, S., Bulic-Jakus, F., Jezek, D., & Sincic, N.
(2020). Teratoma Growth Retardation by HDACi Treatment of the Tumor Embryonal Source. Cancers, 12(11), 3416.
https://doi.org/10.3390/cancers12113416